Research and development
Key indicators
Selected geographical area: Canada
-
298,850 full-time equivalents16,500
(annual change) -
$46.9 billion9.3%
(year-over-year change)
More research and development indicators
Selected geographical area: Canada
-
$16.6 billion4.5%
(annual change)
-
$15.1 billion-3.2%
(annual change)
Filter results by
Search HelpKeyword(s)
Survey or statistical program
Results
All (8)
All (8) ((8 results))
- Articles and reports: 11-621-M2023016Description: This research study examines the economic impact of the semiconductor industry in Canada in 2020 as it relates to several economic concepts, such as sales and revenue, employment, research and development, and international trade. The study is based on a custom list of 561 firms in the industry provided by Innovation, Science and Economic Development Canada.Release date: 2023-11-10
- Articles and reports: 11-621-M2023001Description: This study examines the economic footprint created by the Canadian research and development pharmaceutical sector on the Canadian economy in 2020, including a focus on the contribution of Innovative Medicines Canada’s members. While the impact of the sector’s medical research is well known, less known are the economic impacts of the sector on the Canadian economy, such as the value generated, the jobs supported and the investments made.Release date: 2023-01-30
- Articles and reports: 11-621-M2022002Description:
This study examines the economic footprint created by the Canadian research and development pharmaceutical sector on the Canadian economy in 2019, including a focus on the contribution of Innovative Medicines Canada’s members. While the impact of the sector’s medical research is well known, less known are the economic impacts of the sector on the Canadian economy, such as the value generated, the jobs supported and the investments made.
Release date: 2022-01-28 - Articles and reports: 11-621-M2021003Description:
This study examines the economic footprint created by the Canadian research and development pharmaceutical sector on the Canadian economy in 2018, including a focus on the contribution of Innovative Medicines Canada’s members. While the impact of the sector’s medical research is well known, less known are the economic impacts of the sector on the Canadian economy, such as the value generated, the jobs supported and the investments made.
Release date: 2021-05-07 - Articles and reports: 15-206-X2009026Geography: CanadaDescription:
This paper presents estimates of intangible investment in Canada for the purpose of innovation, advertising and resource extraction. It first expands upon work by Beckstead and Gellatly (2003), Baldwin and Hanel (2003), Beckstead and Gellatly (2003), Beckstead and Vinodrai (2003) and Baldwin and Beckstead (2003) who argue that the scope of innovative activity extends beyond research and development (R&D) as defined by the Frascati Manual. It extends the definition of innovative activities to include all scientific and engineering expenditures - regardless of whether they are market-based or produced with a firm. The paper also considers expenditures on intangible items such as brands or resource exploration.
The paper contributes to the existing literature by creating intangible investment estimates (science and engineering knowledge, advertising, mineral exploration by industry) using Statistics Canada's high quality and internally consistent databases. It produces estimates that accord with other intangibles studies (Corrado, Hulten and Sichel 2005, 2006; Jalava, Ahmavarra and Alanen 2007) and shows that traditional R&D type investment estimates account for about a quarter of intangible science and engineering investments.
Release date: 2009-12-02 - Articles and reports: 88F0006X2006002Description:
This study provides a statistical portrait of the strategies Canadian companies used in conducting research and development between 1997 and 2002. It is based on data from the Survey of Research and Development in Canadian Industry.
Release date: 2006-05-02 - Articles and reports: 88-003-X20010025752Geography: CanadaDescription:
With revenues of almost $2 billion, what are the characteristics and activities of firms that use or develop biotechnology as an important part of their firm's activities? Human Health biotechnology dominates both the revenue and spending in the biotechnology sector. Read this enlightening article for further details including dicussion on the geographic location and size of Canadian biotechnology firms.
Release date: 2001-05-02 - Articles and reports: 88-003-X20000035763Geography: CanadaDescription:
The growing trend towards a knowledge-based economy has impacted the way research is funded and performed in Canadian universities. As higher quality estimates of R&D activities by this sector are of increasing importance to policy makers, Statistics Canada has begun substantial revisions to the methods for calculating estimates for higher education R&D. The implementation of this plan will provide substantially improved estimates of both dollar values and personnel counts for this sector.
Release date: 2000-10-06
Data (0)
Data (0) (0 results)
No content available at this time.
Analysis (8)
Analysis (8) ((8 results))
- Articles and reports: 11-621-M2023016Description: This research study examines the economic impact of the semiconductor industry in Canada in 2020 as it relates to several economic concepts, such as sales and revenue, employment, research and development, and international trade. The study is based on a custom list of 561 firms in the industry provided by Innovation, Science and Economic Development Canada.Release date: 2023-11-10
- Articles and reports: 11-621-M2023001Description: This study examines the economic footprint created by the Canadian research and development pharmaceutical sector on the Canadian economy in 2020, including a focus on the contribution of Innovative Medicines Canada’s members. While the impact of the sector’s medical research is well known, less known are the economic impacts of the sector on the Canadian economy, such as the value generated, the jobs supported and the investments made.Release date: 2023-01-30
- Articles and reports: 11-621-M2022002Description:
This study examines the economic footprint created by the Canadian research and development pharmaceutical sector on the Canadian economy in 2019, including a focus on the contribution of Innovative Medicines Canada’s members. While the impact of the sector’s medical research is well known, less known are the economic impacts of the sector on the Canadian economy, such as the value generated, the jobs supported and the investments made.
Release date: 2022-01-28 - Articles and reports: 11-621-M2021003Description:
This study examines the economic footprint created by the Canadian research and development pharmaceutical sector on the Canadian economy in 2018, including a focus on the contribution of Innovative Medicines Canada’s members. While the impact of the sector’s medical research is well known, less known are the economic impacts of the sector on the Canadian economy, such as the value generated, the jobs supported and the investments made.
Release date: 2021-05-07 - Articles and reports: 15-206-X2009026Geography: CanadaDescription:
This paper presents estimates of intangible investment in Canada for the purpose of innovation, advertising and resource extraction. It first expands upon work by Beckstead and Gellatly (2003), Baldwin and Hanel (2003), Beckstead and Gellatly (2003), Beckstead and Vinodrai (2003) and Baldwin and Beckstead (2003) who argue that the scope of innovative activity extends beyond research and development (R&D) as defined by the Frascati Manual. It extends the definition of innovative activities to include all scientific and engineering expenditures - regardless of whether they are market-based or produced with a firm. The paper also considers expenditures on intangible items such as brands or resource exploration.
The paper contributes to the existing literature by creating intangible investment estimates (science and engineering knowledge, advertising, mineral exploration by industry) using Statistics Canada's high quality and internally consistent databases. It produces estimates that accord with other intangibles studies (Corrado, Hulten and Sichel 2005, 2006; Jalava, Ahmavarra and Alanen 2007) and shows that traditional R&D type investment estimates account for about a quarter of intangible science and engineering investments.
Release date: 2009-12-02 - Articles and reports: 88F0006X2006002Description:
This study provides a statistical portrait of the strategies Canadian companies used in conducting research and development between 1997 and 2002. It is based on data from the Survey of Research and Development in Canadian Industry.
Release date: 2006-05-02 - Articles and reports: 88-003-X20010025752Geography: CanadaDescription:
With revenues of almost $2 billion, what are the characteristics and activities of firms that use or develop biotechnology as an important part of their firm's activities? Human Health biotechnology dominates both the revenue and spending in the biotechnology sector. Read this enlightening article for further details including dicussion on the geographic location and size of Canadian biotechnology firms.
Release date: 2001-05-02 - Articles and reports: 88-003-X20000035763Geography: CanadaDescription:
The growing trend towards a knowledge-based economy has impacted the way research is funded and performed in Canadian universities. As higher quality estimates of R&D activities by this sector are of increasing importance to policy makers, Statistics Canada has begun substantial revisions to the methods for calculating estimates for higher education R&D. The implementation of this plan will provide substantially improved estimates of both dollar values and personnel counts for this sector.
Release date: 2000-10-06
Reference (0)
Reference (0) (0 results)
No content available at this time.
- Date modified: